Early initiation of Dapagliflozin and its effect on health related quality of life in acute heart failure: a randomised controlled trial.
April 01, 2024
Journal of Pakistan Medical Association - Volume 74, No. 4, Pages 621-625
Therapeutic efficacy and drug safety comparison of one-week Vonoprazan triple therapy with two-weeks Esomeprazole triple therapy in Helicobacter pylori infection: Findings from a single-centre randomized clinical trial in population of Pakistan.
February 11, 2024
Journal of the Pakistan Medical Association - Volume 74(3), Pages 432–435
Efficacy and Cost-Effectiveness, Comparison of 7-Days Vonoprazan Versus 14-Days Esomeprazole Based Triple Therapies for Treating Helicobacter Pylori Infection in Pakistani Population: A Randomized Clinical Trial
December 01, 2023
JAMC - Volume 35(4 Suppl 1), Pages 746-51
Effect Of Sglt2 Inhibitor Dapagliflozin On Sodium, Potassium And Creatinine Levels In Patients With Acute Heart Failure
December 01, 2023
JAMC - Volume 35(4 Suppl 1), Pages 715–720
The effect of Dapagliflozin on renal functions in hospitalized patients with Acute Heart Failure
December 01, 2023
Pakistan Journal of Medical Sciences - Volume 39(6), Pages 1695-1700
Evaluation Of Anti-Inflammatory Efficacy Of Ascorbic Acid After Third Molar Surgery.
August 10, 2023
Journal of Ayub Medical College - Volume 35(3), Article Number 442-446